{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:40:12Z","timestamp":1772890812696,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.anl.2019.12.007","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T18:22:55Z","timestamp":1578680575000},"page":"632-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["MiRNA-506 presents multiple tumor suppressor activities by targeting EZH2 in nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"47","author":[{"given":"Da-Chuan","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Xiao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2019.12.007_bib0001","first-page":"381","article-title":"Nasopharyngeal carcinoma incidence and mortality in China in 2010","volume":"33","author":"Wei","year":"2014","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.anl.2019.12.007_bib0002","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1044579X02000858","article-title":"Epidemiology of nasopharyngeal carcinoma","volume":"12","author":"Yu","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.anl.2019.12.007_bib0003","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hed.23363","article-title":"Radiation-induced squamous cell carcinoma of the nasopharynx after radiotherapy for nasopharyngeal carcinoma","volume":"36","author":"Chan","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2019.12.007_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10100381","article-title":"Involving the microRNA targetome in esophageal-cancer development and behavior","volume":"10","author":"Dias","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anl.2019.12.007_bib0005","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/jcp.26514","article-title":"Treating cancer with microRNA replacement therapy: a literature review","volume":"233","author":"Hosseinahli","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.anl.2019.12.007_bib0006","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1159\/000493459","article-title":"miR-184 inhibits tumor invasion, migration and metastasis in nasopharyngeal carcinoma by targeting notch2","volume":"49","author":"Zhu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.anl.2019.12.007_bib0007","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3233\/CBM-170964","article-title":"Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1","volume":"22","author":"Gao","year":"2018","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.anl.2019.12.007_bib0008","first-page":"2053","article-title":"MiR-99a inhibits cell proliferation of nasopharyngeal carcinoma by targeting mTOR and serves as a prognostic factor","volume":"23","author":"Wu","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.anl.2019.12.007_bib0009","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/path.4348","article-title":"MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4\/6-FOXM1 axis in ovarian cancer","volume":"233","author":"Liu","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.anl.2019.12.007_bib0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/onc.2014.9","article-title":"miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer","volume":"34","author":"Wen","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.anl.2019.12.007_bib0011","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/aps.2014.59","article-title":"MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3\u2032UTR","volume":"35","author":"Wang","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.anl.2019.12.007_bib0012","doi-asserted-by":"crossref","first-page":"62778","DOI":"10.18632\/oncotarget.11294","article-title":"The emerging role of miR-506 in cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.anl.2019.12.007_bib0013","article-title":"MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.anl.2019.12.007_bib0014","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10735-006-9042-9","article-title":"The polycomb group protein enhancer of zeste 2: its links to DNA repair and breast cancer","volume":"37","author":"Zeidler","year":"2006","journal-title":"J Mol Histol"},{"key":"10.1016\/j.anl.2019.12.007_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13045-017-0547-3","article-title":"The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter","volume":"11","author":"Gan","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.anl.2019.12.007_bib0016","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jb\/mvu054","article-title":"Targeting histone methyltransferase EZH2 as cancer treatment","volume":"156","author":"Kondo","year":"2014","journal-title":"J Biochem"},{"key":"10.1016\/j.anl.2019.12.007_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108265","article-title":"Prognostic value of polycomb proteins EZH2, BMI1 and SUZ12 and histone modification H3K27me3 in colorectal cancer","volume":"9","author":"Benard","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.anl.2019.12.007_bib0018","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1541-7786.MCR-14-0034","article-title":"EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma","volume":"12","author":"Gao","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.anl.2019.12.007_bib0019","doi-asserted-by":"crossref","first-page":"11319","DOI":"10.18632\/oncotarget.2435","article-title":"EZH2 promotes angiogenesis through inhibition of miR-1\/Endothelin-1 axis in nasopharyngeal carcinoma","volume":"5","author":"Lu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.anl.2019.12.007_bib0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.soc.2015.03.008","article-title":"Nasopharyngeal carcinoma","volume":"24","author":"Kamran","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.anl.2019.12.007_bib0021","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anl.2019.12.007_bib0022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1748-717X-6-29","article-title":"MicroRNA expression profiles in human cancer cells after ionizing radiation","volume":"6","author":"Niemoeller","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.anl.2019.12.007_bib0023","doi-asserted-by":"crossref","first-page":"11111","DOI":"10.1158\/0008-5472.CAN-07-2858","article-title":"MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy","volume":"67","author":"Weidhaas","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.anl.2019.12.007_bib0024","article-title":"MiR-874-3p suppresses cell proliferation and invasion by targeting ADAM19 in nasopharyngeal carcinoma","author":"Feng","year":"2019","journal-title":"Panminerva Med"},{"key":"10.1016\/j.anl.2019.12.007_bib0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4149\/neo_2018_181109N847","article-title":"Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma","volume":"66","author":"Yi","year":"2019","journal-title":"Neoplasma"},{"key":"10.1016\/j.anl.2019.12.007_bib0026","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.12659\/MSM.915624","article-title":"Improved radiotherapy sensitivity of nasopharyngeal carcinoma cells by miR-29-3p targeting COL1A1 3\u2032-UTR","volume":"25","author":"Guo","year":"2019","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.anl.2019.12.007_bib0027","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1111\/jcmm.14365","article-title":"Targeting EZH2 as a novel therapeutic strategy for sorafenib-resistant thyroid carcinoma","volume":"23","author":"Wang","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.anl.2019.12.007_bib0028","doi-asserted-by":"crossref","first-page":"32586","DOI":"10.18632\/oncotarget.5309","article-title":"MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.anl.2019.12.007_bib0029","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbrc.2016.09.055","article-title":"EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3","volume":"479","author":"Luo","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.anl.2019.12.007_bib0030","doi-asserted-by":"crossref","first-page":"85442","DOI":"10.18632\/oncotarget.20006","article-title":"miR-21 modulates the effect of EZH2 on the biological behavior of human lung cancer stem cells in vitro","volume":"8","author":"Xia","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.anl.2019.12.007_bib0031","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00404-018-4768-7","article-title":"miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2","volume":"297","author":"Wang","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.anl.2019.12.007_bib0032","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.biopha.2016.11.053","article-title":"miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt\/beta-catenin signaling pathway","volume":"85","author":"Zhang","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.anl.2019.12.007_bib0033","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.28160","article-title":"The basics of epithelial-mesenchymal transition (EMT): a study from a structure, dynamics, and functional perspective","author":"Das","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.anl.2019.12.007_bib0034","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.anl.2019.12.007_bib0035","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.anl.2019.12.007_bib0036","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.biocel.2012.10.009","article-title":"EZH2 is regulated by ERK\/AKT and targets integrin alpha2 gene to control epithelial-mesenchymal transition and anoikis in colon cancer cells","volume":"45","author":"Ferraro","year":"2013","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814619309411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814619309411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:37:08Z","timestamp":1759952228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814619309411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0385814619309411"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2019.12.007","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiRNA-506 presents multiple tumor suppressor activities by targeting EZH2 in nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2019.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Oto-Rhino-Laryngological Society of Japan Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}